Inspire Investing’s Castle Biosciences CSTL Stock Holding History

Inspire Investing’s Portfolio CSTL Stock Details CSTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$639K	Sell	17,978 -11,069	-38%	-$334K	0.03%	601
2026 Q2	$693K	Buy	29,047 +8,002	+38%	+$178K	0.03%	520
2026 Q1	$517K	Buy	21,045 +9,034	+75%	+$296K	0.03%	596
2025 Q4	$467K	Sell	12,011 -7,876	-40%	-$254K	0.04%	552
2025 Q3	$453K	Buy	19,887 +770	+4%	+$15.6K	0.04%	631
2025 Q2	$390K	Buy	19,117 +1,964	+11%	+$36.4K	0.04%	501
2025 Q1	$343K	Sell	17,153 -28,597	-63%	-$708K	0.04%	584
2024 Q4	$1.22M	Buy	45,750 +3,234	+8%	+$98.5K	0.14%	166
2024 Q3	$1.21M	Buy	42,516 +5,349	+14%	+$136K	0.12%	175
2024 Q2	$809K	Buy	+37,167	New	+$828K	0.09%	241

Other funds holding CSTL

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Harbor Capital Advisors Chicago, Illinois $1.48B AUM 30.88% 1-Year Est. Return

FBT

First Bank & Trust Brookings, South Dakota $687M AUM 18.35% 1-Year Est. Return

Diversify Advisory Services Sandy, Utah $6.69B AUM 18.85% 1-Year Est. Return

Diversify Wealth Management Sandy, Utah $6.69B AUM 22.4% 1-Year Est. Return

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

Oak Harvest Investment Services Houston, Texas $1.07B AUM 32.83% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Inspire Investing's CSTL Position: Q3 2026 in Review

Inspire Investing reduced its Castle Biosciences (CSTL) stake by 38% in Q3 2026, selling an estimated $334K and leaving 17,978 shares worth $639K. The position accounts for 0.03% of the portfolio, ranked #601.

Inspire Investing first reported a position in CSTL in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.22M in Q4 2024. 24 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

Inspire Investing held 17,978 shares of Castle Biosciences worth $639K as of Q3 2026.
Inspire Investing sold 11,069 Castle Biosciences shares in Q3 2026, an estimated $334K.
Castle Biosciences made up 0.03% of Inspire Investing's portfolio in Q3 2026, its #601 holding.
Inspire Investing first reported a position in Castle Biosciences in Q2 2024 and has held it in 10 quarters since.
Inspire Investing's Castle Biosciences position peaked at $1.22M in Q4 2024.
24 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Inspire Investing's 13F filing for Q3 2026, filed 22 Oct 2026.